Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01726517 |
|---|---|
| Brief Title: | Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects |
| First Submitted : | November 10, 2012 |
| First Submitted that Met QC Criteria : | November 10, 2012 |
| First Posted : | November 15, 2012 (Estimate) |
| Results First Submitted : | November 7, 2014 |
| Results First Submitted that Met QC Criteria : | November 7, 2014 |
| Results First Posted : | November 17, 2014 (Estimate) |
| Certification/Extension First Submitted : | March 17, 2014 |
| Certification/Extension First Submitted that Met QC Criteria : | March 17, 2014 |
| Certification/Extension First Posted : | April 14, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 19, 2018 |
| Last Update Posted : | November 16, 2018 |